| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $458K | -62.5% |
| R&D Expense | $3.2M | -46.1% |
| SG&A Expense | $5.4M | +13.3% |
| Operating Income | -$15.6M | +8.3% |
| Net Income | -$17.1M | +13.6% |
| EPS (Basic) | -$34.19 | -5080.3% |
| EPS (Diluted) | -$34.19 | -5080.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.0M | -90.9% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $447K | -27.3% |
| Current Assets | $1.5M | -87.7% |
| Total Assets | $6.3M | -66.3% |
| Current Liabilities | $5.8M | +15.8% |
| Total Liabilities | $7.8M | -44.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | +9.2% |
| Capital Expenditures | $3.9M | +2177.9% |
| Investing Cash Flow | -$3.9M | -1360.6% |
| Financing Cash Flow | $3.0M | -81.8% |
| Free Cash Flow | -$13.4M | -25.5% |
| Stockholders' Equity |
| -$1.5M |
| -133.3% |